PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains
- Author
- PICAUD, Sarah1 ; DA COSTA, David3 ; BRADNER, James E8 9 ; TANIERE, Philippe4 ; O'SULLIVAN, Brendan4 ; MÜLLER, Susanne1 ; SCHWALLER, Juerg6 ; STANKOVIC, Tatjana3 ; KNAPP, Stefan1 2 7 ; THANASOPOULOU, Angeliki6 ; FILIPPAKOPOULOS, Panagis1 ; FISH, Paul V5 ; PHILPOTT, Martin1 ; FEDOROV, Oleg1 ; BRENNAN, Paul1 ; BUNNAGE, Mark E5 ; OWEN, Dafydd R5
[1] Structural Genomics Consortium, University of Oxford, Oxford, United Kingdom
[2] Target Discovery Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom
[3] School of Cancer Sciences, University of Birmingham, United Kingdom
[4] Department of Cellular Pathology, Queen Elizabeth Medical Centre, Birmingham, United Kingdom
[5] Pfizer Worldwide Medicinal Chemistry, Pfizer Worldwide R&D, Ramsgate Road, Sandwich, United Kingdom
[6] Laboratory for Childhood Leukemia, Department of Biomedicine, University of Basel and Basel University Children's Hospital, Basel, Switzerland
[7] Department of Biochemistry and Molecular Biology, School of Medicine and Health Sciences, George Washington University, Washington, DC, United States
[8] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States
[9] Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States - Source
Cancer research (Chicago, Ill.). 2013, Vol 73, Num 11, pp 3336-3346, 11 p ; ref : 46 ref
- CODEN
- CNREA8
- ISSN
- 0008-5472
- Scientific domain
- Medical oncology; Pharmacology drugs
- Publisher
- American Association for Cancer Research, Philadelphia, PA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Ciblage Cible Inhibiteur protéique Interaction Bromodomaine
- Keyword (en)
- Targeting Target Protein inhibitor Interaction Bromodomain
- Keyword (es)
- Blancado Blanco Inhibidor proteico Interacción
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents
- Discipline
- Pharmacological treatments Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 27448249
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1158/0008-5472.CAN-12-3292 
https://dx.doi.org/10.1158/0008-5472.CAN-12-3292
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/0008-5472.CAN-12-3292\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:83:\"PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains\";s:9:\"\u0000*\u0000jtitle\";s:31:\"Cancer research (Chicago, Ill.)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Cancer res. (Chic. Ill.)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"73\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"3336\";s:8:\"\u0000*\u0000epage\";s:4:\"3346\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-5472\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"PICAUD\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Sarah\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:15:\"DA COSTA, David\";i:1;s:16:\"BRADNER, James E\";i:2;s:17:\"TANIERE, Philippe\";i:3;s:19:\"O'SULLIVAN, Brendan\";i:4;s:16:\"M\u00dcLLER, Susanne\";i:5;s:16:\"SCHWALLER, Juerg\";i:6;s:18:\"STANKOVIC, Tatjana\";i:7;s:13:\"KNAPP, Stefan\";i:8;s:23:\"THANASOPOULOU, Angeliki\";i:9;s:24:\"FILIPPAKOPOULOS, Panagis\";i:10;s:12:\"FISH, Paul V\";i:11;s:16:\"PHILPOTT, Martin\";i:12;s:13:\"FEDOROV, Oleg\";i:13;s:13:\"BRENNAN, Paul\";i:14;s:15:\"BUNNAGE, Mark E\";i:15;s:14:\"OWEN, Dafydd R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CNREA8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:83:\"PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/0008-5472.CAN-12-3292\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:83:\"PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains\";s:9:\"\u0000*\u0000jtitle\";s:31:\"Cancer research (Chicago, Ill.)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Cancer res. (Chic. Ill.)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"73\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"3336\";s:8:\"\u0000*\u0000epage\";s:4:\"3346\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-5472\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"PICAUD\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Sarah\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:15:\"DA COSTA, David\";i:1;s:16:\"BRADNER, James E\";i:2;s:17:\"TANIERE, Philippe\";i:3;s:19:\"O'SULLIVAN, Brendan\";i:4;s:16:\"M\u00dcLLER, Susanne\";i:5;s:16:\"SCHWALLER, Juerg\";i:6;s:18:\"STANKOVIC, Tatjana\";i:7;s:13:\"KNAPP, Stefan\";i:8;s:23:\"THANASOPOULOU, Angeliki\";i:9;s:24:\"FILIPPAKOPOULOS, Panagis\";i:10;s:12:\"FISH, Paul V\";i:11;s:16:\"PHILPOTT, Martin\";i:12;s:13:\"FEDOROV, Oleg\";i:13;s:13:\"BRENNAN, Paul\";i:14;s:15:\"BUNNAGE, Mark E\";i:15;s:14:\"OWEN, Dafydd R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CNREA8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:83:\"PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/0008-5472.CAN-12-3292\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/0008-5472.CAN-12-3292\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:83:\"PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains\";s:9:\"\u0000*\u0000jtitle\";s:31:\"Cancer research (Chicago, Ill.)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Cancer res. (Chic. Ill.)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"73\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"3336\";s:8:\"\u0000*\u0000epage\";s:4:\"3346\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-5472\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"PICAUD\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Sarah\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:15:\"DA COSTA, David\";i:1;s:16:\"BRADNER, James E\";i:2;s:17:\"TANIERE, Philippe\";i:3;s:19:\"O'SULLIVAN, Brendan\";i:4;s:16:\"M\u00dcLLER, Susanne\";i:5;s:16:\"SCHWALLER, Juerg\";i:6;s:18:\"STANKOVIC, Tatjana\";i:7;s:13:\"KNAPP, Stefan\";i:8;s:23:\"THANASOPOULOU, Angeliki\";i:9;s:24:\"FILIPPAKOPOULOS, Panagis\";i:10;s:12:\"FISH, Paul V\";i:11;s:16:\"PHILPOTT, Martin\";i:12;s:13:\"FEDOROV, Oleg\";i:13;s:13:\"BRENNAN, Paul\";i:14;s:15:\"BUNNAGE, Mark E\";i:15;s:14:\"OWEN, Dafydd R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CNREA8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:83:\"PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/0008-5472.CAN-12-3292\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:83:\"PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains\";s:9:\"\u0000*\u0000jtitle\";s:31:\"Cancer research (Chicago, Ill.)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Cancer res. (Chic. Ill.)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"73\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"3336\";s:8:\"\u0000*\u0000epage\";s:4:\"3346\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-5472\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"PICAUD\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Sarah\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:15:\"DA COSTA, David\";i:1;s:16:\"BRADNER, James E\";i:2;s:17:\"TANIERE, Philippe\";i:3;s:19:\"O'SULLIVAN, Brendan\";i:4;s:16:\"M\u00dcLLER, Susanne\";i:5;s:16:\"SCHWALLER, Juerg\";i:6;s:18:\"STANKOVIC, Tatjana\";i:7;s:13:\"KNAPP, Stefan\";i:8;s:23:\"THANASOPOULOU, Angeliki\";i:9;s:24:\"FILIPPAKOPOULOS, Panagis\";i:10;s:12:\"FISH, Paul V\";i:11;s:16:\"PHILPOTT, Martin\";i:12;s:13:\"FEDOROV, Oleg\";i:13;s:13:\"BRENNAN, Paul\";i:14;s:15:\"BUNNAGE, Mark E\";i:15;s:14:\"OWEN, Dafydd R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CNREA8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:83:\"PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/0008-5472.CAN-12-3292\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:83:\"PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains\";s:9:\"\u0000*\u0000jtitle\";s:31:\"Cancer research (Chicago, Ill.)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Cancer res. (Chic. Ill.)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"73\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"3336\";s:8:\"\u0000*\u0000epage\";s:4:\"3346\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-5472\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"PICAUD\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Sarah\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:15:\"DA COSTA, David\";i:1;s:16:\"BRADNER, James E\";i:2;s:17:\"TANIERE, Philippe\";i:3;s:19:\"O'SULLIVAN, Brendan\";i:4;s:16:\"M\u00dcLLER, Susanne\";i:5;s:16:\"SCHWALLER, Juerg\";i:6;s:18:\"STANKOVIC, Tatjana\";i:7;s:13:\"KNAPP, Stefan\";i:8;s:23:\"THANASOPOULOU, Angeliki\";i:9;s:24:\"FILIPPAKOPOULOS, Panagis\";i:10;s:12:\"FISH, Paul V\";i:11;s:16:\"PHILPOTT, Martin\";i:12;s:13:\"FEDOROV, Oleg\";i:13;s:13:\"BRENNAN, Paul\";i:14;s:15:\"BUNNAGE, Mark E\";i:15;s:14:\"OWEN, Dafydd R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CNREA8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:83:\"PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
